Fexlamose
Fexlamose (AER-01) is a thiol-modified carbohydrate agent with mucolytic property. Fexlamose cleaves disulfides to cause mucolysis. Fexlamose can be used for researchs of chronic obstructive pulmonary disease (COPD) and muco-obstructive lung diseases (MOLD) [1][2].
Product Specifications
CAS Number
1285607-08-0
Product Name Alternative
AER-01; MUC-031
UNSPSC
12352005
Target
Mucin
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.93
Solubility
DMSO : 40 mg/mL (ultrasonic)
Smiles
SC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CS
Molecular Formula
C12H22O9S2
Molecular Weight
374.43
References & Citations
[1]Vu SP, et al., Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions. Int J Mol Sci. 2025 Feb 28;26 (5) :2184.|[2]Addante A, et al. A. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases. Eur Respir J. 2023 May 25;61 (5) :2202022.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PDE4 (PDE4B) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B12]](https://cdn.genprice.uk/products/937/6868c34d994c49e6dc3f39e7/imageurl/ta503477bm.webp)
TA503477BM 100 µL
PDE4 (PDE4B) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B12]
Sign In for Pricing
View Details